|O'Brochta Researchers Developed a Powerful Forward-Genetics Transposon Technology||
Researchers in the laboratory of Dr. David O’Brochta, at the University of Maryland Institute of Bioscience and Biotechnology Research (IBBR) and Department of Entomology (ENT), have developed a powerful forward-genetics transposon technology that can be used to determine gene functions from the phenotypes arising from transposon insertion mutations. The group published the findings, titled “piggyBac transposon remobilization and enhancer detection in Anopheles mosquitoes”, in the Sept 27 issue of PNAS.
|Dr. Mariuzza's Research Group Finding Selected by F1000||
Researchers in the laboratory of Dr. Roy Mariuzza, at the University of Maryland Institute of Bioscience and Biotechnology Research (IBBR) and Department of Cell Biology and Molecular Genetics (CBMG), have developed unique tools for probing the influence of the interaction of immune cell receptors CD4 and MHC class II on T-cell activation and development. The group published the findings, titled “Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4–HLA-DR1 complex”, in the September 10 issue of PNAS.
|Bringing Next-Generation Sequencing Technology to the UM Research Community||
The Institute for Bioscience and Biotechnology Research (IBBR) is expanding its core services to include high throughput sequencing, based on the recent purchase of an Illumina HiSeq 1000 instrument plus supporting equipment. The instrument is located in the IBBR DNA Sequencing Facility on the 5th floor of the Plant Sciences Building on the College Park campus, which has offered Sanger sequencing for many years. The purchase of this “Next-Gen” instrument, the first on the UM campus, was facilitated by Dr.
|Dr. Osnat Herzberg Awarded Funding for Pre-Clinical Studies to Develop Compound for the Treatment of Giardia Disease||
Dr. Osnat Herzberg, Professor at the University of Maryland Institute of Bioscience and Biotechnology Research (IBBR) and Department of Chemistry and Biochemistry, has been awarded funding for pre-clinical studies to develop a compound for the treatment of Giardia disease. Dr. Herzberg’s project, which is funded as a subcontract managed by SAIC-Frederick, is part of the NIH Therapeutics for Rare and Neglected Diseases (TRND) program, a component of a congressionally mandated program to encourage and speed the development of new drugs for rare and neglected diseases.
|Dr. Scott Walsh's Research Featured in International Innovation||
Dr. Scott Walsh, Assistant Professor at the University of Maryland Institute of Bioscience and Biotechnology Research (IBBR) and Department of Cell Biology and Molecular Genetics, is featured in the August issue of International Innovation by Research Media Ltd. in London. International Innovation is the leading resource for disseminating global communication to the wider scientific, technology and research communities. The August issue highlights Dr.
|Harley King Recipient of 2011 Cosmos Scholars Grant and Distinguished Teaching Assistant Award||
IBBR and MOCB graduate student Harley King, from the laboratory of Dr. Shunyuan Xiao (IBBR and the Department of Plant Sciences and Landscape Architecture) has been selected as the recipient of two distinguished awards.
|Nuss to Head New Institute for Bioscience and Biotechnology Research||
New Institute to lead Maryland to national leadership in scientific and technological advances and economic development
COLLEGE PARK, Md - The University of Maryland today announced the appointment of Donald L. Nuss as the founding director of the new Institute for Bioscience and Biotechnology Research (IBBR).
|Virus-Built Wearable Batteries Could Power Military||
Batteries, built by viruses, could someday be sprayed onto military uniforms as wearable power sources.
Teams of researchers, one from MIT, one from the University of Maryland, have used two different viruses to create the cathode and anode for a lithium ion battery.
|Mtech Bioprocess Scale-Up Facility to Expand to IBBR Shady Grove||
The Maryland Technology Enterprise Institute (Mtech) Bioprocess Scale-Up Facility (BSF) will double its facilities and staff, expand into Shady Grove, acquire new equipment, and create a pilot plant for biofuels in College Park through the support of a $200,000 Shared Resource Grant from the Maryland Biotechnology Center.
|Identifying enzymes to explode superbugs||
IBBR's Dr. Daniel Nelson teams up with researchers from Georgia Insititute of Technology to publish new research in IOP Publishing's Physical Biology.
New research yields pioneering methods to identify lytic enzymes for use in combatting superbugs in the wake of rising antibiotic resistance.
With the worrying rise of antibiotic-resistant superbugs like MRSA, scientists from a wide range of disciplines are teaming up to identify alternative therapies to keep them at bay.